Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
Researchers Discover What Lies Behind the Death of Stem Cells
Researchers have identified key processes that control stem cell survival, providing insights that could improve their use in medicine.
Scientists Discover Neurochemical Imbalance in Schizophrenia
Researchers discovers that neurons from schizophrenia patients secrete higher amounts of three neurotransmitters.
Building Replacement Kidneys in the Lab
Milestone reached in work to build replacement kidneys in the lab.
Diabetes Researchers Find Faster Way to Create Insulin-producing Cells
A new protocol can turn stem cells into reliable, insulin-producing cells in about six weeks.
Wiping the Slate Clean
Erasing cellular memory and resetting human stem cells.
Combining Antibodies, Iron Nanoparticles and Magnets Steers Stem Cells to Injured Organs
Study published in nature communications details targeted nanomedicine therapy to regenerate heart muscle injured by heart attack.
Turning Human Skin Cells Into Immune-Fighting White Blood Cells
The fast and safe technique developed at the Salk Institute circumvents problems that have hindered regenerative medicine.
Clinical Trial to Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes
UC San Diego is initial site for first-in-human testing of implanted cell therapy.
In Directing Stem Cells, Context Matters
The surface cells are grown on has a profound effect on differentiation.
Scroll Up
Scroll Down
Return
Complicity Complications in Induced Pluripotent Stem Cell Research
Mark Brown, Professor, University of Wisconsin, Speaking at Stem Cells World Congress 2010.
Date Posted: Sunday, July 18, 2010
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



New Induced Stem Cells May Unmask Cancer at Earliest Stage
A team of Wisconsin scientists observes the onset of the blood cancer leukemia by coaxing healthy and diseased human bone marrow to become embryonic-like stem cells.
Tuesday, February 08, 2011
Gene Regulating Human Brain Development Identified
New findings by Wisconsin-Madison scientists reveal the main genetic factor responsible for instructing cells at the earliest stages of embryonic development.
Friday, July 02, 2010
Liver Cells Grown From Patients’ Skin Cells Could Lead to Treatment of Liver Diseases
Wisconsin scientists have successfully produced liver cells from patients’ skin cells opening the possibility of treating liver diseases.
Monday, October 12, 2009
California Company Licenses Human Embryonic Stem Cell Technology from WARF
BioTime signs licensing agreement with WARF for 173 patents and patent applications relating to human embryonic stem cell technology created at the UW-Madison.
Tuesday, January 15, 2008
Stem Cells Show Power to Predict Disease, Drug Toxicity
Scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease.
Monday, December 10, 2007
UW-Madison Scientists Guide Human Skin Cells to Embryonic State
Researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells in a paper to be published online.
Thursday, November 22, 2007
Stem Cell Therapy Rescues Motor Neurons in ALS Model
University of Wisconsin-Madison scientists show that it is possible to rescue the dying neurons characteristics of ALS by using cell-based therapies.
Wednesday, August 01, 2007
UW Launches Study Testing Adult Stem Cells for Repair of Heart Damage
The University of Wisconsin will take part in a clinical trial that involves investigation of patient’s own stem cells to treat severe coronary artery disease.
Tuesday, March 20, 2007
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv